Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 551-575 of 781 matching filings.

Per page
25
Current page
23
CT ORDER File 001-37722

CT ORDER filing

Filing date
19 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-230137

S-8

Filing date
07 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
07 Mar 2019
Reporting date
07 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SCHEDULE 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-228967

EFFECT filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228967

424B5

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SC 13G/A

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SCHEDULE 13G HOLDINGS REPORT AMENDMENT

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-228967

S-3/A

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Feb 2019
Reporting date
06 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G filing

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
07 Feb 2019
Reporting date
05 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-217573

424B5

Filing date
07 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-217573

424B5

Filing date
05 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SC 13G/A

Filing date
05 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .